Cryptococcus-related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its clinical implications

Current Fungal Infection Reports

Volumn 5, Issue 4, 2011, Pages 252-261

  Wiesner, Darin L ^a   Boulware, David R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Anti inflammatory therapy; Antifungal therapy; Antiretroviral therapy; Biomarkers; CM IRIS; Cryptococcal meningitis; HIV; Immune reconstitution inflammatory syndrome; Immunology; Pathogenesis; Review; Risk stratification

Indexed keywords

EID: 84881548555     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-011-0064-8     Document Type: Review

References (50)

1. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am. 2006;20:507-44. v-vi. (Pubitemid 44375117)
2. Perfect JR. Cryptococcus neoformans: a sugar-coated killer with designer genes. FEMS Immunol Med Microbiol. 2005;45:395-404. (Pubitemid 41258130)
3. Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol. 2000;38:407-17. (Pubitemid 32045754)
4. Chaka W, Verheul AF, Vaishnav VV, Cherniak R, Scharringa J, Verhoef J, et al. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun. 1997;65:272-8. (Pubitemid 27008933)
5. Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun. 1986;51:218-23. (Pubitemid 16200022)
6. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun. 1994;62:1507-12. (Pubitemid 24136940)
7. Pietrella D, Cherniak R, Strappini C, Perito S, Mosci P, Bistoni F, et al. Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans. Infect Immun. 2001;69:2808-14. (Pubitemid 32332168)
8. Frases S, Nimrichter L, Viana NB, Nakouzi A, Casadevall A. Cryptococcus neoformans capsular polysaccharide and exopolysaccharide fractions manifest physical, chemical, and antigenic differences. Eukaryot Cell. 2008;7:319-27. (Pubitemid 351959699)
9. Yauch LE, Mansour MK, Shoham S, Rottman JB, Levitz SM. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun. 2004;72:5373-82. (Pubitemid 39223426)
10. Yauch LE, Mansour MK, Levitz SM. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo. Infect Immun. 2005;73:8429-32. (Pubitemid 41740337)
11. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol. 2001;166:4620-6. (Pubitemid 32233748)
12. Levitz SM, Specht CA. The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 2006;6:513-24. (Pubitemid 43725735)
13. Kozel TR, Wilson MA, Pfrommer GS, Schlageter AM. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect Immun. 1989;57:1922-7. (Pubitemid 19186863)
14. van Asbeck EC, Hoepelman AI, Scharringa J, Herpers BL, Verhoef J. Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. BMC Microbiol. 2008;8:229.
15. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med. 1995;182:389-400.
16. Wozniak KL, Levitz SM. Cryptococcus neoformans enters the endolysosomal pathway of dendritic cells and is killed by lysosomal components. Infect Immun. 2008;76:4764-71.
17. • Bicanic T, Muzoora C, Brouwer AE, Meintjes G, Longley N, Taseera K, et al. Independent association between rate of clearance of infection and clinical outcome of HIV associated cryptococcal meningitis: analysis of a combined cohort of 262 patients. Clin Infect Dis. 2009;49:702-9. This article reports on the important association between survival and the quantitative rate of cryptococcal clearance from the CSF.
18. Siddiqui AA, Brouwer AE, Wuthiekanun V, Jaffar S, Shattock R, Irving D, et al. IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis. J Immunol. 2005;174:1746-50.
19. Jarvis J, Meintjes G, Rebe K, Williams N, Bicanic T, Williams A, et al. Adjunctive IFN-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial [Abstract 40]. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI). Boston, MA; Feb 28, 2011.
20. Voelz K, Lammas DA, May RC. Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans. Infect Immun. 2009;77:3450-7.
21. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, et al. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J Immunol. 2007;179:5367-77.
22. 2 responses are nonprotective in cryptococcosis.
23. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206:299-311.
24. Zelante T, De Luca A, D'Angelo C, Moretti S, Romani L. IL-17/Th17 in anti-fungal immunity: what's new? Eur J Immunol. 2009;39:645-8.
25. Hardison SE, Wozniak KL, Kolls JK, Wormley Jr FL. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection. Infect Immun. 2010;78:5341-51.
26. Wozniak KL, Hardison SE, Kolls JK, Wormley FL. Role of IL-17A on resolution of pulmonary C. neoformans infection. PLoS One. 2011;6:e17204.
27. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol. 2007;37:2695-706. (Pubitemid 47578289)
28. • Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7: e1000384. This article details a prospective Ugandan cohort and the evolving pattern of serum cytokines and chemokines over time that are associated with IRIS.
29. • Boulware DR, Bonham SC, Meya DB, Wiesner DL, Park GS, Kambugu A, et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis. 2010;202:962-70. This article reports on the inflammatory cytokines and chemokines present in the CSF of persons with and without IRIS at the time of their initial infection and at the time of IRIS.
30. • Jarvis J. CSF cytokine profiles in patients with HIV-associated cryptococcal meningitis: correlates with clinical outcome. Presented at the 8th International Conference on Cryptococcus and Cryptococcosis. Charleston, SC; May 4, 2011. This abstract presents confirmatory data on CSF cytokine profiles; an initial paucity of inflammation was associated with later IRIS.
31. Stone SF, Price P, Keane NM, Murray RJ, French MA. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med. 2002;3:21-7. (Pubitemid 34189592)
32. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958-69.
33. Almeida GM, Andrade RM, Bento CA. The capsular polysaccharides of Cryptococcus neoformans activate normal CD4(+) T cells in a dominant Th2 pattern. J Immunol. 2001;167:5845-51. (Pubitemid 33062777)
34. Hoag KA, Lipscomb MF, Izzo AA, Street NE. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am J Respir Cell Mol Biol. 1997;17:733-9. (Pubitemid 127348664)
35. Gilliet M, Liu YJ. Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells. Hum Immunol. 2002;63:1149-55. (Pubitemid 36025989)
36. McKenna K, Beignon AS, Bhardwaj N. Plasmacytoid dendritic cells: linking innate and adaptive immunity. J Virol. 2005;79:17-27. (Pubitemid 39648359)
37. Dale DC, Liles WC, Llewellyn C, Price TH. Effects of granulocyte- macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers. Am J Hematol. 1998;57:7-15. (Pubitemid 28047192)
38. van Pelt LJ, Huisman MV, Weening RS, von dem Borne AE, Roos D, van Oers RH. A single dose of granulocyte-macrophage colony-stimulating factor induces systemic interleukin-8 release and neutrophil activation in healthy volunteers. Blood. 1996;87:5305-13. (Pubitemid 26189874)
39. Chen G-H, Olszewski MA, McDonald RA, Wells JC, Paine III R, Huffnagle GB, et al. Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis. Am J Pathol. 2007;170:1028-40. (Pubitemid 47339370)
40. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-8.
41. Diehl S, Rincon M. The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol. 2002;39:531-6. (Pubitemid 35341492)
42. Kambugu A, Meya DB, Rhein J, O'Brien M, Janoff EN, Ronald AR, et al. Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clin Infect Dis. 2008;46:1694-701. (Pubitemid 351706766)
43. Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, et al. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007;45:76-80. (Pubitemid 46984619)
44. • Chang CC. Patients with cryptococcal meningitis who attain CSF sterility pre-ART commencement experience improved outcomes in the first 6 months. Presented at the 8th International Conference on Cryptococcus and Cryptococcosis. Charleston, SC; May 5, 2011. This abstract presents convincing data from a prospective cohort on the importance of CSF culture sterility before ART initiation and/or before fluconazole dosing is reduced to fungistatic levels.
45. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.
46. Bicanic T, Jarvis J, Loyse A, Jackson A, Muzoora C, Wilson D, et al. Determinants of acute outcome and long-term survival in HIV-associated cryptococcal meningitis: Results from a combined cohort of 523 patients [Abstract 892]. Presented at the Conference on Retroviruses and Opportunistic Infections (CROI). Boston, MA; March 3, 2011.
47. Bahr N, Rolfes MAR, Musubire A, Nabeta H, Lo M, Meya DB, et al. The impact of routine electrolyte supplementation during amphotericin induction therapy in resource-limited settings. Presented at the 8th International Conference on Cryptococcus and Cryptococcosis. Charleston, SC; May 4, 2011.
48. Longley N, Muzoora C, Taseera K, Mwesigye J, Rwebembera J, Chakera A, et al. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda. Clin Infect Dis. 2008;47:1556-61.
49. Grant PM, Komarow L, Andersen J, Sereti I, Pahwa S, Lederman MM, et al. Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection. PLoS One. 2010;5:e11416.
50. • Bicanic T, Meintjes G, Rebe K, Williams A, Loyse A, Wood R, et al. Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study. J Acquir Immune Defic Syndr. 2009;51:130-4. This cohort is the first prospective study to detail the incidence of Cryptococcus-related IRIS in sub-Saharan Africa.